Job title: Director, Translational Medicine & Biomarkers
Tooba Cheema is leading the translational research and biomarker strategy for oncolytic viral immunotherapies into the clinic for Oncorus Inc. Tooba is an experienced immuno-oncologist advancing projects from early discovery, lead selection through translational medicine and clinical development. Prior to Oncorus, Tooba led the non-clinical pharmacology and translational efforts advancing T cell therapies in combination with antibodies for hematological malignancies and solid tumors at Unum Therapeutics through successful submissions of multiple Investigational New Drug Applications (IND). At Momenta Pharmaceuticals, she contributed to the non-clinical biological characterization of biologics and biosimilars for autoimmune and oncology indications. Tooba received her post-doctoral training at Massachusetts General Hospital under the fellowship from the American Brain Tumor Association, evaluating combination therapies with oncolytic virus for the treatment of Glioblastoma. Tooba has a Ph.D. in Pharmacology from the University of Michigan-Ann Arbor and B.Sc in Biochemistry from Tufts University.
4.45 | 1.45 Live Audience Q+A 4:45 pm
day: Day One
4.05 | 1.05 Safety & Pharmacodynamic Biomarker Strategy for Viral Immunotherapy for Cancer 4:05 pm
day: Day One